Pseudopolyps are associated with increased fecal calprotectin levels in patients with Inflammatory Bowel Disease in clinical and endoscopic remission

被引：0
|
作者：
Spigarelli De Rabago, I. [1 ]
Suarez Ferrer, C. [2 ]
Poza Cordon, J. [2 ]
Martin Arranz, E. [2 ]
Sanchez Azofra, M. [2 ]
Rueda Garcia, J. L. [2 ]
Suarez Cabredo, C. G. [1 ]
Hernandez Perez, M. [1 ]
Martin Arranz, M. D. [2 ]
机构：
[1] La Paz Univ Hosp, Gastroenterol, Madrid, Spain
[2] Univ Autonoma Madrid, Hosp la Paz Inst Hlth Res, IdiPAZ La Paz Univ Hosp, Gastroenterol, Madrid, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.337
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P211
引用
收藏
页码：S270 / S271
页数：3
相关论文
共 50 条
  • [11] INCREASED DIETARY CARBOHYDRATE IS ASSOCIATED WITH CLINICAL ACTIVITY AND WITH ENDOSCOPIC REMISSION IN INFLAMMATORY BOWEL DISEASE
    Sheasgreen, Christopher
    Mohammadi, Aylia
    Boland, Karen
    Atwal, Simen
    Borowski, Krzysztof
    Stempak, Joanne M.
    Silverberg, Mark S.
    GASTROENTEROLOGY, 2017, 152 (05) : S421 - S421
  • [12] Faecal Calprotectin in Inflammatory Bowel Disease: What Levels Determine Clinical Remission?
    Dhaliwal, Amritpal
    Tomkins, Claudia
    Cheung, Michelle C.
    Zeino, Zeino
    Nwokolo, Chuka
    Smith, Steve
    Harmston, Christopher
    Arasaradnam, Ramesh
    GASTROENTEROLOGY, 2014, 146 (05) : S429 - S430
  • [13] Utility of Fecal Calprotectin Levels for the Diagnosis of Inflammatory Bowel Disease in Patients with Spondyloarthritis
    Espinosa, Maria
    Ramos Giraldez, Consuelo
    Merino, Carolina
    Ruiz Antoran, Belen
    Campos, Jose
    Barbadillo, Carmen
    Godoy, Hilda
    Agudo, Belen
    Gonzalez, Yago
    Luis Andreu, Jose
    Sanz, Jesus
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [14] ASSOCIATION OF FECAL CALPROTECTIN WITH ENDOSCOPIC AND HISTOLOGY ACTIVITY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
    Crawford, Erin
    Gestrich, Catherine
    Malay, Sindhoosha
    Sferra, Thomas
    Saab, Shahrazad
    Moses, Jonathan
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S16 - S16
  • [15] Decrease in Butyric Acid in fecal matter in patients with Inflammatory Bowel Disease is associated with the levels of secretory Immunoglobulin A and fecal calprotectin
    Izquierdo, L. V. Parra
    de Avila, J.
    Ramos, A.
    Chila-Moreno, L.
    Bello-Gualtero, J. M.
    Valdes, A.
    Morantes, S.
    Madronero, J.
    Bautista-Molano, W.
    Delgado, F.
    Florez-Sarmiento, C.
    Romero-Sanchez, C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I482 - I482
  • [16] ASSOCIATION OF FECAL CALPROTECTIN WITH ENDOSCOPIC AND HISTOLOGY ACTIVITY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
    Crawford, Erin
    Gestrich, Catherine
    Malay, Sindhoosha
    Sferra, Thomas
    Saab, Shahrazad
    Moses, Jonathan
    GASTROENTEROLOGY, 2020, 158 (03) : S27 - S27
  • [17] Clinical Significance of Pseudopolyps for Patients With Inflammatory Bowel Disease
    Lewis, Ayanna E.
    Kirchgesner, Julien
    Dray, Xavier
    Svrcek, Magali
    Beaugerie, Laurent
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S179 - S180
  • [18] Fecal calprotectin in inflammatory bowel disease
    Walsham, Natalie E.
    Sherwood, Roy A.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2016, 9 : 21 - 29
  • [19] Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
    D'Haens, Geert
    Ferrante, Marc
    Vermeire, Severine
    Baert, Filip
    Noman, Maja
    Moortgat, Liesbeth
    Geens, Patricia
    Iwens, Doreen
    Aerden, Isolde
    Van Assche, Gert
    Van Olmen, Gust
    Rutgeerts, Paul
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) : 2218 - 2224
  • [20] Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease
    Dai, Cong
    Cao, Qin
    Jiang, Min
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (09) : E46 - E47
12345